The Evolution of Distributed Manufacturing in Cell Therapies

Distributed manufacturing in cell therapies involves a network of centrally coordinated sites spread across various locations. This model differs from decentralized manufacturing, which operates multiple independent sites, and point of care manufacturing, where therapies are produced at the treatment location. Distributed manufacturing aims to enhance patient access to life-saving therapies by increasing scalability and flexibility, which is essential given the demand fluctuations in cell and gene therapies. By employing multiple production sites, companies can better manage capacity constraints and ensure prompt delivery of therapies to patients.